Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma.
- 1 July 1985
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 3 (7), 977-981
- https://doi.org/10.1200/jco.1985.3.7.977
Abstract
Thirty-five eligible patients with disseminated malignant melanoma received intramuscular recombinant leukocyte interferon (IFN-rA), 50 X 10(6) U/m2 three times weekly (TIW) for an intended duration of 12 weeks concomitant with daily oral cimetidine, 1,200 mg/d in four divided doses. For all study participants, the median survival time was six months. Among 21 "good risk" patients (performance score [PS] 0, 1 and no prior chemotherapy), we observed seven partial regressions (33%). Six patients had stability of disease (29%), seven had immediate disease progression, and one discontinued treatment after two doses without tumor evaluation due to side effects. Times to disease progression of five patients with regressions of soft-tissue disease were 2.1, 3.3, 3.5, 3.7, and 4.3 months. Two patients had partial regressions of lung nodules for 2.0 and 3.8 months. We observed one regression among 14 "poor risk" patients (PS 2, 3, or prior chemotherapy). A 46-year-old woman with prior treatment had a partial regre...This publication has 11 references indexed in Scilit:
- Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.Journal of Clinical Oncology, 1984
- HUMAN-LEUKOCYTE (ALPHA) INTERFERON IN METASTATIC MALIGNANT-MELANOMA - THE AMERICAN-CANCER-SOCIETY PHASE-II TRIAL1984
- Metastatic malignant melanoma: Regression induced by combined treatment with interferon [HuIFN-α(Le)] and cimetidineInternational Journal of Cancer, 1983
- Evaluation of human lymphoblastoid interferon in advanced malignant melanomaCancer, 1983
- Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer PatientsAnnals of Internal Medicine, 1982
- Combined interferon-antimetabolite therapy of murine L1210 leukemiaCancer, 1981
- INITIAL EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT DISEASEThe Lancet, 1980
- Interferon as an Inhibitor of Cell Growth: Studies with Mouse Melanoma CellsExperimental Biology and Medicine, 1980
- INHIBITION OF GROWTH OF B-16 MURINE MALIGNANT-MELANOMA BY EXOGENOUS INTERFERON1980
- Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR miceEuropean Journal of Cancer (1965), 1978